28 August 2016 - Young melanoma patient Jeffrey Paterson helped to win the campaign for Government funding of Keytruda, but didn't benefit from it himself.

The Unitec architecture graduate helped deliver the ultimately successful petitions to Parliament in March seeking state funding of Keytruda, a new and extremely expensive medicine that is extending the lives of many patients diagnosed with inoperable, terminal melanoma.

Read New Zealand Herald article